2008-09 NIH Funding for Medicine Faculty
Einstein faculty members listed under "Internal Medicine" as primary or secondary appointments received significant NIH funding from September 2008 to September 2009.
Whether new grants, competing renewals, or supplements, these endeavors required serious new effort by the investigator and underwent intensive peer review.
Center Grant Competing Renewals
Center Cores
- David Shafritz, Liver Pathobiology and Gene Theraphy Research Core Center
Clinical and Translational Science Awards
New R01s
- Sridhar Mani, Chemical Modulation of Orphan Nuclear Receptor Function
- Mary Fabry, Modulators of Nitric Oxide Synthase Activity in Sickle Cell
Competing R01s
Supplements
- I. David Goldman, Core Support for Cancer Center
- Steamson Chua, Leptin Receptor and the Obesity/Diabetes Syndrome
- David Shafritz, Liver Pathobiology and Gene Theraphy Research Core Center
- Gary Schwartz, Sensory Controls of Hyperphagia in Obesity
- Allan Wolkoff, Liver Cell Membrane Protein-Expression and Function
- Mark Czaja, Modulation of Acute Liver Injury
- Harry Shamoon, Clinical and Translational Science Award (UL1)
- David Shafritz, Protein Synthesis in Normal and Regenerating Liver
- Jeffrey Pessin, Diabetes Research and Training Center
- I. David Goldman, Core Support for Cancer Center
- Joshua Nosanchuk, Antibody Protection in Histoplasmosis
Clinical Investigator
- Colette Knight, Role of Sirt1 in Regulating Glucose Homeostasis and Insulin Action in Aging
Training Grants
Support for Meetings
- Richard Kitsis, Symposium: AHA Council on Basic Cardiovascular Sciences
Interim Support toward R01
- Mariana Dabeva, Gene Expression Pattern of Liver Stem/Progenitor Cells
HRSA Federal